Atlas Trials

Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost

Clinical trial NCT03331770 · COMPLETED

Trial details

NCT number
NCT03331770
Sponsor
Laboratorios Poen
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Primary Open-angle Glaucoma
Start date
2017-01-06
Primary completion
2017-10-06
Enrollment
103

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.